Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies
Clinical trial NCT01188252 · COMPLETED
Trial details
- NCT number
- NCT01188252
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2016-06-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.